trending Market Intelligence /marketintelligence/en/news-insights/trending/qBAYK_fhvh-ItF9239UUrA2 content esgSubNav
In This List

MyoKardia appoints COO

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity

Blog

Insight Weekly: Bank mergers of equals return; energy tops S&P 500; green bond sales to rise


MyoKardia appoints COO

June Lee was appointed MyoKardia Inc.'s COO, joining Radhika Tripuraneni, who was appointed as the company's vice president of medical affairs.

Lee, who will be establishing MyoKardia's portfolio planning function, was on the faculty of the University of California, San Francisco.

Tripuraneni was most recently vice president of medical affairs at Synageva BioPharma, which later became Alexion Pharmaceuticals.